11.18
price down icon1.24%   -0.14
after-market Handel nachbörslich: 11.18
loading

Ars Pharmaceuticals Inc Aktie (SPRY) Neueste Nachrichten

pulisher
Dec 20, 2024

ARS Pharmaceuticals (NASDAQ:SPRY) Trading Down 4% After Insider Selling - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Ars Pharmaceuticals' chief medical officer sells $1.17 million in stock By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 19, 2024

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal - GlobeNewswire

Dec 19, 2024
pulisher
Dec 19, 2024

Ars Pharmaceuticals' chief medical officer sells $1.17 million in stock - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

Insider Selling: ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Insider Sells 100,000 Shares of Stock - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

Ars Pharmaceuticals CEO sells $1.17 million in stock By Investing.com - Investing.com UK

Dec 19, 2024
pulisher
Dec 19, 2024

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Gap UpStill a Buy? - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 18, 2024
pulisher
Dec 18, 2024

ARS Pharmaceuticals to Present at J.P. Morgan's Prestigious Healthcare Conference - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

Franklin Resources Inc. Trims Holdings in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Dec 18, 2024
pulisher
Dec 15, 2024

Insider Sell Alert: Justin Chakma Sells 144,605 Shares of ARS Ph - GuruFocus.com

Dec 15, 2024
pulisher
Dec 14, 2024

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) COO Brian Dorsey Sells 25,000 Shares - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Justin Chakma Sells 27,272 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

ARS Pharmaceuticals (NASDAQ:SPRY) Trading Down 5.5%What's Next? - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals' chief business officer sells $1.77m in stock By Investing.com - Investing.com Australia

Dec 13, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals' chief business officer sells $1.77m in stock - Investing.com India

Dec 13, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals COO Brian Dorsey sells $493,858 in stock By Investing.com - Investing.com Australia

Dec 13, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals COO Brian Dorsey sells $493,858 in stock - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

ARS Pharmaceuticals 宣布在中国、日本和澳大利亚申请批准 neffy® - GlobeNewswire Inc.

Dec 13, 2024
pulisher
Dec 13, 2024

ARS Pharmaceuticals seeks Asia Pacific neffy approvals By Investing.com - Investing.com Canada

Dec 13, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals' chief business officer sells shares worth $657,625 By Investing.com - Investing.com Nigeria

Dec 13, 2024
pulisher
Dec 13, 2024

Ars Pharmaceuticals' chief business officer sells shares worth $657,625 - Investing.com India

Dec 13, 2024
pulisher
Dec 12, 2024

ARS Pharmaceuticals seeks Asia Pacific neffy approvals - Investing.com India

Dec 12, 2024
pulisher
Dec 12, 2024

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia - The Manila Times

Dec 12, 2024
pulisher
Dec 12, 2024

ARS Pharma's Neffy Nasal Spray Seeks Approval in Asia-Pacific After Breakthrough Clinical Results - StockTitan

Dec 12, 2024
pulisher
Dec 09, 2024

SPRYARS Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Dec 09, 2024
pulisher
Dec 08, 2024

NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE INTRAVAIL ROYALTIES - The Eastern Progress Online

Dec 08, 2024
pulisher
Dec 08, 2024

Wexford Capital LP Makes New $3.60 Million Investment in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

(SPRY) Proactive Strategies - Stock Traders Daily

Dec 08, 2024
pulisher
Dec 07, 2024

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Insider Justin Chakma Sells 50,000 Shares - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Cantor Fitzgerald Analysts Lower Earnings Estimates for SPRY - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Ars Pharmaceuticals' chief business officer sells $2.04 million in stock By Investing.com - Investing.com Canada

Dec 07, 2024
pulisher
Dec 06, 2024

Insider Sell: Justin Chakma Sells 90,000 Shares of ARS Pharmaceu - GuruFocus.com

Dec 06, 2024
pulisher
Dec 06, 2024

Jacobs Levy Equity Management Inc. Buys 288,021 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Insider Sell: Eric Karas Sells 10,000 Shares of ARS Pharmaceuticals Inc (SPRY) - GuruFocus.com

Dec 06, 2024
pulisher
Dec 05, 2024

Ars Pharmaceuticals director Laura Shawver sells shares for $2.69 million By Investing.com - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 04, 2024

Ars Pharmaceuticals chief commercial officer sells $140,423 in stock - Investing.com India

Dec 04, 2024
pulisher
Dec 04, 2024

Ars Pharmaceuticals' chief business officer sells $1.2 million in stock By Investing.com - Investing.com Canada

Dec 04, 2024
pulisher
Dec 04, 2024

Ars Pharmaceuticals director Laura Shawver sells shares for $2.69 million - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Ars Pharmaceuticals' chief business officer sells $1.2 million in stock - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost - The Manila Times

Dec 04, 2024
pulisher
Dec 04, 2024

ARS Pharmaceuticals Launches Free Nasal Spray Allergy Program for K-12 Schools, Tackles Critical Safety Need - StockTitan

Dec 04, 2024
pulisher
Dec 04, 2024

Miura Global Management LLC Takes $3.92 Million Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Dec 04, 2024
pulisher
Dec 02, 2024

Neurelis Offs Neffy Stake for $208M - San Diego Business Journal

Dec 02, 2024
pulisher
Nov 30, 2024

Trade Alert: Chief Business Officer & Secretary Of ARS Pharmaceuticals Justin Chakma Has Sold Stock - Simply Wall St

Nov 30, 2024
pulisher
Nov 28, 2024

Connor Clark & Lunn Investment Management Ltd. Takes Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives $24.00 Consensus Target Price from Brokerages - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Insider Sell: Justin Chakma Sells 100,000 Shares of ARS Pharmace - GuruFocus.com

Nov 28, 2024
pulisher
Nov 27, 2024

US Growth Stocks With High Insider Ownership For November 2024 - Simply Wall St

Nov 27, 2024
pulisher
Nov 22, 2024

ARS Scores Deal Worth Up to $465M - San Diego Business Journal

Nov 22, 2024
pulisher
Nov 20, 2024

ARS Pharmaceuticals: Demand Curve Is Key Unknown (NASDAQ:SPRY) - Seeking Alpha

Nov 20, 2024
pulisher
Nov 20, 2024

ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):